Not checked for notices yet.
RIVA – a phase IIa study of rituximab and varlilumab in relapsed or refractory B-cell malignancies: study protocol for a randomized controlled trial
Sean H. Lim, Kim M. Linton, Graham P. Collins and 11 more (opens in a new tab)
Trials · 2018
doi:10.1186/s13063-018-2996-6 (opens in a new tab)
Cited by papers we hold 1
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.